GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of appeal — 22 things I got wrong before I got it right — 60 comments in the full submission. View in context.
1k
c/insurancefights·submitted 7 months ago by u/elin_varga

appeal — 22 things I got wrong before I got it right

Appealbranch of 11 comments

The title is the argument: appeal — 22 things I got wrong before I got it right. Here is the rest of it. Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover. A peer-to-peer conversation puts…

Read the full submission and all 60 comments →

This branch

11 comments, started 7 months ago
u/prior_auth_painMOD253 points·7 months ago

Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.

replysharereportpermalink
[removed]183 points·7 months ago

[removed by moderator]

replysharereportpermalink
u/tomas_lehtinen152 points·7 months ago

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

replysharereportpermalink
u/runa_wikstrom92 points·7 months ago·edited

I would not skip the peer-to-peer.

This is the whole method. Answer the criterion they named, not the decision in general.

replysharereportpermalink
u/ahmed_abubakar36 points·7 months ago

I would not skip the peer-to-peer.

Disagreeing with this line: the deadline runs from the letter date and treating it otherwise is expensive.

replysharereportpermalink
u/emeka_delgado-36 points·7 months ago

ask for the clinical policy bulletin by number

replysharereportpermalink
u/ahmed_abubakar140 points·7 months ago

Has a peer-to-peer been offered or requested?

replysharereportpermalink
u/emeka_delgado45 points·7 months ago

a peer-to-peer call is often faster than a written appeal

replysharereportpermalink
u/elin_vargaOP18 points·7 months ago

Which country and which plan year are we talking about?

replysharereportpermalink
load more comments (1) →
u/plain_titration_2024172 points·7 months ago·edited

Documented eighteen months of what had been tried in a one-page table. That table was the appeal.

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.